HT
ADMA icon

Headlands Technologies’s ADMA Biologics ADMA Stock Holding History

Headlands Technologies’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$811K Buy
+89,985
New +$1.42M 0.09% 258
2025
Q4 		– Sell
-10,583
Closed -$155K – 658
2025
Q3 		$155K Buy
10,583
+10,033
+1,824% +$172K 0.01% 555
2025
Q2 		$10K Buy
+550
New +$11.2K ﹤0.01% 1014
2024
Q2 		– Sell
-2,584
Closed -$17.1K – 1112
2024
Q1 		$17.1K Buy
+2,584
New +$14.1K ﹤0.01% 937

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Headlands Technologies's ADMA Position: Q1 2026 in Review

Headlands Technologies opened a new position in ADMA Biologics (ADMA) in Q1 2026: 89,985 shares worth $811K. The stake represents 0.09% of the portfolio and ranks #258 among its holdings. This is a return to the name: Headlands Technologies previously reported a position in ADMA as recently as Q3 2025.

Headlands Technologies first reported a position in ADMA in Q1 2024 and has held it in 4 quarters since. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • Headlands Technologies held 89,985 shares of ADMA Biologics worth $811K as of Q1 2026.
  • ADMA Biologics was a new Headlands Technologies position in Q1 2026.
  • ADMA Biologics made up 0.09% of Headlands Technologies's portfolio in Q1 2026, its #258 holding.
  • Headlands Technologies first reported a position in ADMA Biologics in Q1 2024 and has held it in 4 quarters since.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on Headlands Technologies's 13F filing for Q1 2026, filed 13 May 2026.